Literature DB >> 23657084

Imaging features to distinguish malignant and benign branch-duct type intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis.

Kyung Won Kim1, Seong Ho Park, Junhee Pyo, Soon Ho Yoon, Jae Ho Byun, Moon-Gyu Lee, Katherine M Krajewski, Nikhil H Ramaiya.   

Abstract

OBJECTIVE: To systematically determine the imaging findings for distinguishing malignant and benign branch-duct type intraductal papillary mucinous neoplasms (BD-IPMNs), including mixed type, and their diagnostic value through meta-analysis of published studies.
BACKGROUND: Management of BD-IPMNs, including mixed type, largely relies on imaging findings. The current knowledge on imaging findings to distinguish malignant and benign BD-IPMNs has weak evidence and is mostly from scattered individual retrospective studies.
METHODS: Thorough literature search in Ovid-MEDLINE and EMBASE databases was conducted to identify studies where findings of computed tomography, magnetic resonance imaging, and endoscopic ultrasonography of BD-IPMNs with or without main pancreatic duct (MPD) dilatation were correlated with surgical/pathological findings. Review of 1128 article candidates, including full-text review of 102 articles, identified 23 eligible articles with a total of 1373 patients for meta-analysis. Dichotomous data regarding distinction between malignant and benign BD-IPMNs were pooled using random effects model to obtain the diagnostic odds ratios (DORs) and their 95% confidence intervals (CIs) of various individual imaging findings for diagnosing malignant BD-IPMN.
RESULTS: Presence of mural nodules revealed the highest pooled DOR (95% CI) of 6.0 (4.1-8.8) followed by MPD dilatation [3.4 (2.3-5.2)], thick septum/wall [unadjusted, 3.3 (1.5-6.9); publication bias-adjusted, 2.3 (0.9-5.5)], and cyst size greater than 3 cm [2.3 (1.5-3.5)]. Multilocularity and multiplicity of the cystic lesions did not reveal statistically significant association with malignancy.
CONCLUSIONS: Presence of mural nodules should be regarded highly suspicious for malignancy warranting a surgical excision whereas cyst size greater than 3 cm, MPD dilatation (5-9 mm), or thick septum/wall may better be managed by careful observation and/or further evaluation.

Entities:  

Mesh:

Year:  2014        PMID: 23657084     DOI: 10.1097/SLA.0b013e31829385f7

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  47 in total

1.  Comparison between MRI with MR cholangiopancreatography and endoscopic ultrasonography for differentiating malignant from benign mucinous neoplasms of the pancreas.

Authors:  Jiyoung Hwang; Young Kon Kim; Ji Hye Min; Woo Kyung Jeong; Seong Sook Hong; Hyun-Joo Kim
Journal:  Eur Radiol       Date:  2017-08-04       Impact factor: 5.315

2.  Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography.

Authors:  Hirofumi Harima; Seiji Kaino; Shuhei Shinoda; Michitaka Kawano; Shigeyuki Suenaga; Isao Sakaida
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

3.  Evaluation of the International Consensus Guidelines for the Surgical Resection of Intraductal Papillary Mucinous Neoplasms.

Authors:  Mariko Tsukagoshi; Kenichiro Araki; Fumiyoshi Saito; Norio Kubo; Akira Watanabe; Takamichi Igarashi; Norihiro Ishii; Takahiro Yamanaka; Ken Shirabe; Hiroyuki Kuwano
Journal:  Dig Dis Sci       Date:  2017-06-30       Impact factor: 3.199

4.  Determining the natural history of pancreatic cystic neoplasms: a Manitoban cohort study.

Authors:  Jon Broughton; Jeremy Lipschitz; Michael Cantor; Dana Moffatt; Ahmed Abdoh; Andrew McKay
Journal:  HPB (Oxford)       Date:  2016-01-29       Impact factor: 3.647

5.  Interobserver agreement for detection of malignant features of intraductal papillary mucinous neoplasms of the pancreas on MDCT.

Authors:  Richard K G Do; Seth S Katz; Marc J Gollub; Jian Li; Jennifer LaFemina; Emily C Zabor; Chaya S Moskowitz; David S Klimstra; Peter J Allen
Journal:  AJR Am J Roentgenol       Date:  2014-11       Impact factor: 3.959

Review 6.  Pearls and pitfalls of imaging features of pancreatic cystic lesions: a case-based approach with imaging-pathologic correlation.

Authors:  Kumi Ozaki; Hiroshi Ikeno; Yasuharu Kaizaki; Kazuya Maeda; Shohei Higuchi; Nobuyuki Kosaka; Hirohiko Kimura; Toshifumi Gabata
Journal:  Jpn J Radiol       Date:  2020-08-25       Impact factor: 2.374

Review 7.  The Role of Endoscopic Ultrasound in the Diagnosis of Cystic Lesions of the Pancreas.

Authors:  Philippe Lévy; Vinciane Rebours
Journal:  Visc Med       Date:  2018-06-08

8.  Intraductal papillary mucinous neoplasms of the pancreas: radiological predictors of malignant transformation and the introduction of bile duct dilation to current guidelines.

Authors:  Albert Strauss; Matthew Birdsey; Stefan Fritz; Bogata D Schwarz-Bundy; Frank Bergmann; Thilo Hackert; Hans-Ullrich Kauczor; Lars Grenacher; Miriam Klauss
Journal:  Br J Radiol       Date:  2016-03-09       Impact factor: 3.039

9.  Podoplanin expression in the cyst wall correlates with the progression of intraductal papillary mucinous neoplasm.

Authors:  Koji Shindo; Shinichi Aishima; Kenoki Ohuchida; Minoru Fujino; Yusuke Mizuuchi; Masami Hattori; Takao Ohtsuka; Shoji Tokunaga; Kazuhiro Mizumoto; Masao Tanaka; Yoshinao Oda
Journal:  Virchows Arch       Date:  2014-07-03       Impact factor: 4.064

Review 10.  Treatment of branch-duct intraductal papillary mucinous neoplasms of the pancreas: state of the art.

Authors:  Stefano Crippa; Alessandra Piccioli; Maria Chiara Salandini; Chiara Cova; Francesca Aleotti; Massimo Falconi
Journal:  Updates Surg       Date:  2016-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.